Luisa Castro Laria - Concepedia

Author

Luisa Castro Laria

Also Known As

Federico Arguelles Arias, J M Herrerias Gutierrez, L Castro Laria, L. Castro Laria, Luisa Castro Laria, M Rojas Feria, Valle Sánchez García

Publications

488

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen Macarena Hospital Universitario Virgen del Rocío Universidad de Sevilla Hospital Juan Ramón Jiménez

About

Luisa Castro Laria is an author at Hospital Universitario Virgen Macarena.

Luisa Castro Laria

Publications

271

Citations

H-Index

Page 1

	Year	Citations
Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study Ignacio Marín‐Jiménez, Pilar Nos, Eugeni Domènech, The American Journal of Gastroenterology	2016	57
Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months Federico Argüelles‐Arias, María Fernanda Guerra Veloz, Raúl Perea Amarillo, Digestive Diseases and Sciences	2017	44
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results Federico Argüelles‐Arias, María Fernanda Guerra Veloz, Raúl Perea Amarillo, European Journal of Gastroenterology & Hepatology	2017	42
Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori Carolina Moreno Márquez, Paula Álvarez, Teresa Valdés Delgado, Revista Española de Enfermedades Digestivas	2021	22
A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients Blas José Gómez Rodríguez, Luisa Castro Laria, Federico Argüelles‐Arias, Revista Española de Enfermedades Digestivas	2017	21
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response. Laura Lorenzo González, Teresa Valdés Delgado, Juan María Vázquez Morón, Revista Española de Enfermedades Digestivas	2020	19
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months María Fernanda Guerra Veloz, Juan María Vázquez Morón, María Belvis Jiménez, Revista Española de Enfermedades Digestivas	2018	18
Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data María Fernanda Guerra Veloz, María Belvis Jiménez, Teresa Valdés Delgado, Therapeutic Advances in Gastroenterology	2019	18
Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease María Fernanda Guerra Veloz, Federico Argüelles‐Arias, Luisa Castro Laria, World Journal of Gastroenterology	2018	17
Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity María Belvis Jiménez, Pedro Hergueta-Delgado, Blas Gómez Rodríguez, Endoscopy International Open	2021	13

Page 1